Rankings
▼
Calendar
INVA
Innoviva, Inc.
$1B
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$331M
-15.4% YoY
Gross Profit
$318M
95.8% margin
Operating Income
-$37M
-11.2% margin
Net Income
$214M
64.6% margin
EPS (Diluted)
$2.37
Cash Flow
Operating Cash Flow
$202M
Free Cash Flow
$202M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$666M
Stockholders' Equity
$566M
Cash & Equivalents
$291M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$331M
$392M
-15.4%
Gross Profit
$318M
$392M
-19.0%
Operating Income
-$37M
$375M
-109.8%
Net Income
$214M
$266M
-19.5%
← Q4 2021
All Quarters
Q1 2022 →
INVA FY 2022 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena